July 2026

EJPPS Volume 31 Issue 2

In this volume:

Peer Review Papers

• Impact of Aseptic Dispensing on the Incidence of Nosocomial Infections: A Retrospective Study in a Hospital

• Characterization And In-Vitro Optimization Of Caffeine-Incorporated Mucoadhesive Microsphere

• Expanding test panels for pharmaceutical microbiology: Making an informed decision

• Beyond Threshold Monitoring: A Bayesian and Time Series Framework for Predictive Contamination Control in Aseptic Manufacturing

• Comparative Endotoxin Determination of Naturally Occurring Endotoxins (NOEs) from Pharmaceutical Facility Isolates

---

Technical Review

• Adapting a Monoclonal Antibody (mAb) Facility for Gene Therapy Production

• Sphingosomes: A Novel Vesicular Drug Delivery System

• Analytical Methodology for Pharmaceutical Extractables and Leachables: A Comprehensive Approach for Containers and Closures

• Unique Device Identifier Deployment: Role and Challenges in Traceability and Expedited Device Approvals Across the European Union and United States

• Mechanical Particle Size Reduction Strategies for BCS Class II Drugs: Beyond Nanocrystals and Nanosuspensions

• Formulation, Optimization, and Predictive Modelling of Naratriptan Hydrochloride Dry Powder Inhaler for Enhanced Pulmonary Delivery in Migraine Management

---

Editorial

• GUEST EDITORIAL: James Drinkwater The Different Risk Profiles of Isolators and RABS.

• PHSS News - Jenni Tranter (Chair)

---

Regulatory Update

 by Malcolm Holmes

• April 2026

• May 2026

• June 2026

---